Peripheral leukocyte count and risk of bleeding in patients with non-valvular atrial fibrillation taking dabigatran: a real-world study

BACKGROUND: The association between peripheral leukocyte count and bleeding events in nonvalvular atrial fibrillation (NVAF) patients treated with dabigatran remains unclear. This study aimed to explore the association between leukocyte count and bleeding events after excluding other confounders in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wei, Wang, Tao, Zhu, Ling-Juan, Wen, Ming-Hua, Hu, Li-Hua, Huang, Xiao, You, Chun-Jiao, Li, Ju-Xiang, Wu, Yan-Qing, Wu, Qing-Hua, Bao, Hui-Hui, Cheng, Xiao-Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797159/
https://www.ncbi.nlm.nih.gov/pubmed/31490268
http://dx.doi.org/10.1097/CM9.0000000000000423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797159/
https://www.ncbi.nlm.nih.gov/pubmed/31490268
http://dx.doi.org/10.1097/CM9.0000000000000423

Ejemplares similares